By achieving these objectives, insights into the complex relationship between the insulin–leptin axis and COPD will be provided, highlighting its potential as a therapeutic target for improving metabolic health and the well-being of patients with COPD in terms of life quality. The gene discussed is LEP; the disease is chronic obstructive pulmonary disease.